1.
|
Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 080200, 08-C-0200, NCI-08-C-0200, NCI-P07341, 8333, NCT00775268
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: J08101, CA180123, NCT00882583
|
|
3.
|
Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: 16 and over Sponsor: Other Protocol IDs: SP-24513/DX-FLT-002, NCT01065805
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: C/24/2011, 2011-005240-10, X-52-58064-011, NCT01662726
|
|
5.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MIMEB, 2009-012607-26, NCT01047059
|
|
6.
|
Phase: Phase II Type: Diagnostic Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: J08134, NA_00017885, 8340, N01CM27018, NCT00963807
|
|
7.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-02012, U10CA021661, CDR0000665163, RTOG 0837, RTOG-0837-ACRIN-6689, NCT01062425
|
|
8.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10852, NCT01174238
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA191-011, NCT01225172
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-8029, N01CM27165, ACRIN-6688, NCT00572728
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 9 to 40 Sponsor: NCI Protocol IDs: 110136, 11-C-0136, NCT01338987
|
|
12.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: I 197811, NCI-2011-03037, NCT01533948
|
|
13.
|
Phase: Phase II Type: Diagnostic, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: 120130, 12-C-0130, NCT01610544
|
|
14.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 120199, 12-C-0199, NCT01679743
|
|
15.
|
Phase: Phase I Type: Diagnostic, Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 100, NCT00159978
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000552705, WCCC-CO-06902, CO 06902, 7898, NCT00499135
|
|
17.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000579311, MAYO-MC0622, MC0622, NCT00575393
|
|
18.
|
Phase: Phase I Type: Diagnostic Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000647210, P30CA022453, WSU-2006-127, PFIZER-WSU-2006-127, 2006-127, NCT00935090
|
|
19.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: OSU-10080, OSU-10080, 8609, NCT01251874
|
|
20.
|
Phase: Phase I Type: Diagnostic Status: Active Age: 21 and under Sponsor: NCI, Other Protocol IDs: WSU 2009-031, NCT01308905
|
|
21.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: ABTC-1101, ABTC-1101, NCT01480050
|
|
22.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CO10907, NCT01540526
|
|
23.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SP-14-0054 / 23061, NCT00414570
|
|
24.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: CDR0000562788, FRE-FNCLCC-FLT-01/0505, EU-20754, FLT 01/0505, NCT00534274
|
|
25.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Diagnostic Status: Approved-not yet active Age: 18 to 86 Sponsor: Other Protocol IDs: TASMC-08-EE-108-CTIL, NCT00688337
|